Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi INVESTIGATING THE ACTIVE SITE(S) OF THE CANNABIDIOL (CBD) COMPOUND
*Corresponding Author:
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
CBD is a non-psychoactive compound (unlike its relative D9- tetrahydrocannabinol) found in the hemp variety of the cannabis plant that has been associated with the relief of mental and physical ailments. Popularly and most recently, people who suffer from mental and physical ailments have sought the molecule in the forms of oils and capsules hoping to seek relief. With its lack of adverse effects and non-toxic, multi-faceted pain-relieving effect this project seeks to answer can the exploration of CBD’s effect on genetics help identify the active site of CBD? This study seeks to examine and identify the mechanisms of Cannabidiol (CBD) using the reaction of CBD oil with calf thymus DNA. HPLC (high performance liquid chromatography) will be used to follow the reaction
